Federal (United States) · Regulations
Subpart C — Labeling
8 sections
8 sections
- 21 C.F.R. § 341.70Labeling of OTC drug products containing ingredients that are used for treating concurrent symptoms (in either a single-ingredient or combination drug product).
- 21 C.F.R. § 341.72Labeling of antihistamine drug products.
- 21 C.F.R. § 341.74Labeling of antitussive drug products.
- 21 C.F.R. § 341.76Labeling of bronchodilator drug products.
- 21 C.F.R. § 341.78Labeling of expectorant drug products.
- 21 C.F.R. § 341.80Labeling of nasal decongestant drug products.
- 21 C.F.R. § 341.85Labeling of permitted combinations of active ingredients.
- 21 C.F.R. § 341.90Professional labeling.